{
    "xml": "<topic id=\"PHP7171\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/verteporfin\" basename=\"verteporfin\" title=\"VERTEPORFIN\">\n<title>VERTEPORFIN</title>\n<body>\n<data name=\"vtmid\">125708009</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_435207013\" title=\"Photosensitisers\">Photosensitisers</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP36309\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/verteporfin\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Following intravenous infusion, verteporfin is activated by local irradiation using non-thermal red light to produce cytotoxic derivatives.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36228\" outputclass=\"indicationsAndDose\" rev=\"1.12\" parent=\"/drugs/verteporfin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Photodynamic treatment of age-related macular degeneration associated with predominantly classic subfoveal choroidal neovascularisation or with pathological myopia (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>6&#8239;mg/m<sup>2</sup>, dose to be given over 10 minutes.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36369\" outputclass=\"contraindications\" rev=\"1.6\" parent=\"/drugs/verteporfin\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Acute porphyria</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36415\" outputclass=\"cautions\" rev=\"1.9\" parent=\"/drugs/verteporfin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Avoid extravasation</ph>; <ph outputclass=\"caution\">biliary obstruction</ph>; <ph outputclass=\"caution\">photosensitivity</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36191\" outputclass=\"interactions\" rev=\"1.10\" parent=\"/drugs/verteporfin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Caution on concomitant use with other photosensitising drugs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54227\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/verteporfin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Back pain</ph>; <ph outputclass=\"sideEffect\">flashing lights</ph>; <ph outputclass=\"sideEffect\">hypercholesterolaemia</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">reduced visual acuity</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>; <ph outputclass=\"sideEffect\">visual-field defects</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hyperaesthesia</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">retinal detachment</ph>; <ph outputclass=\"sideEffect\">subretinal, retinal or vitreous haemorrhage</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Retinal or choroidal vessel non-perfusion</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Chest pain</ph>; <ph outputclass=\"sideEffect\">macular oedema</ph>; <ph outputclass=\"sideEffect\">myocardial infarction</ph>; <ph outputclass=\"sideEffect\">retinal oedema</ph>; <ph outputclass=\"sideEffect\">vasovagal reactions</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36169\" outputclass=\"pregnancy\" parent=\"/drugs/verteporfin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk (teratogenic in <i>animal</i> studies).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36440\" outputclass=\"breastFeeding\" parent=\"/drugs/verteporfin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available&#8212;manufacturer advises avoid breast-feeding for 48 hours after administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36255\" outputclass=\"hepaticImpairment\" parent=\"/drugs/verteporfin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in moderate hepatic impairment.</p>\n<p>Avoid in severe hepatic impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36483\" outputclass=\"directionsForAdministration\" rev=\"1.8\" parent=\"/drugs/verteporfin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For information on administration and light activation, consult product literature.</p>\n</sectiondiv>\n<sectiondiv>\n<p>For <i>intravenous infusion</i> (<i>Visudyne</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5%; reconstitute each 15&#8239;mg with 7&#8239;ml water for injections to produce a 2&#8239;mg/ml solution then dilute requisite dose with infusion fluid to a final volume of 30&#8239;mL and give over 10 minutes; protect infusion from light and administer within 4 hours of reconstitution. Incompatible with sodium chloride infusion.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36140\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/verteporfin\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Photosensitivity&#8212;avoid exposure of unprotected skin and eyes to bright light during infusion and for 48 hours afterwards.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP53563\" outputclass=\"nationalFunding\" rev=\"1.15\" parent=\"/drugs/verteporfin\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA68</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Verteporfin photodynamic therapy for wet age-related macular degeneration (September 2003)</p>\r\n<p>Photodynamic therapy is recommended for wet age-related macular degeneration with a confirmed diagnosis of classic (no occult) subfoveal choroidal neovascularisation and best-corrected visual acuity of 6/60 or better. </p>\r\n<p>Photodynamic therapy is <b>not</b> recommended for wet age-related macular degeneration with predominantly classic but partly occult subfoveal choroidal neovascularisation <i>except</i> in clinical studies.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA68\">www.nice.org.uk/TA68</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP7171-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/verteporfin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77490\" title=\"Powder for solution for infusion\" namespace=\"/drugs/verteporfin/powder-for-solution-for-infusion\">Powder for solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77490\" namespace=\"/drugs/verteporfin/powder-for-solution-for-infusion\" title=\"Powder for solution for infusion\" count=\"1\" rel=\"link\">Powder for solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP7171",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/verteporfin",
    "basename": "verteporfin",
    "title": "VERTEPORFIN",
    "vtmid": "125708009",
    "drugClassification": [
        "Photosensitisers"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Following intravenous infusion, verteporfin is activated by local irradiation using non-thermal red light to produce cytotoxic derivatives.",
                "html": "<p>Following intravenous infusion, verteporfin is activated by local irradiation using non-thermal red light to produce cytotoxic derivatives.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Photodynamic treatment of age-related macular degeneration associated with predominantly classic subfoveal choroidal neovascularisation or with pathological myopia (specialist use only)",
                        "html": "Photodynamic treatment of age-related macular degeneration associated with predominantly classic subfoveal choroidal neovascularisation or with pathological myopia (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "6 mg/m2, dose to be given over 10 minutes.",
                        "html": "<p>6&#8239;mg/m<sup>2</sup>, dose to be given over 10 minutes.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyria",
                "html": "Acute porphyria"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Avoid extravasation",
                "html": "Avoid extravasation"
            },
            {
                "type": "cautions",
                "textContent": "biliary obstruction",
                "html": "biliary obstruction"
            },
            {
                "type": "cautions",
                "textContent": "photosensitivity",
                "html": "photosensitivity"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Caution on concomitant use with other photosensitising drugs.",
                "html": "<p>Caution on concomitant use with other photosensitising drugs.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Back pain",
                        "html": "Back pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flashing lights",
                        "html": "flashing lights",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hypercholesterolaemia",
                        "html": "hypercholesterolaemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "reduced visual acuity",
                        "html": "reduced visual acuity",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "visual-field defects",
                        "html": "visual-field defects",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Hyperaesthesia",
                        "html": "Hyperaesthesia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "retinal detachment",
                        "html": "retinal detachment",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "subretinal, retinal or vitreous haemorrhage",
                        "html": "subretinal, retinal or vitreous haemorrhage",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Retinal or choroidal vessel non-perfusion",
                        "html": "Retinal or choroidal vessel non-perfusion",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Chest pain",
                        "html": "Chest pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "macular oedema",
                        "html": "macular oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myocardial infarction",
                        "html": "myocardial infarction",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "retinal oedema",
                        "html": "retinal oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vasovagal reactions",
                        "html": "vasovagal reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk (teratogenic in animal studies).",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk (teratogenic in <i>animal</i> studies).</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available&#8212;manufacturer advises avoid breast-feeding for 48 hours after administration.",
                "html": "<p>No information available&#8212;manufacturer advises avoid breast-feeding for 48 hours after administration.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in moderate hepatic impairment.\n\nAvoid in severe hepatic impairment.",
                "html": "<p>Use with caution in moderate hepatic impairment.</p><p>Avoid in severe hepatic impairment.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For information on administration and light activation, consult product literature.",
                "html": "<p>For information on administration and light activation, consult product literature.</p>"
            },
            {
                "type": "directionsForAdministration",
                "textContent": "For intravenous infusion (Visudyne ), give intermittently in Glucose 5%; reconstitute each 15 mg with 7 ml water for injections to produce a 2 mg/ml solution then dilute requisite dose with infusion fluid to a final volume of 30 mL and give over 10 minutes; protect infusion from light and administer within 4 hours of reconstitution. Incompatible with sodium chloride infusion.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Visudyne</i>\n<tm tmtype=\"reg\"/>), give intermittently in Glucose 5%; reconstitute each 15&#8239;mg with 7&#8239;ml water for injections to produce a 2&#8239;mg/ml solution then dilute requisite dose with infusion fluid to a final volume of 30&#8239;mL and give over 10 minutes; protect infusion from light and administer within 4 hours of reconstitution. Incompatible with sodium chloride infusion.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Photosensitivity&#8212;avoid exposure of unprotected skin and eyes to bright light during infusion and for 48 hours afterwards.",
                "html": "<p>Photosensitivity&#8212;avoid exposure of unprotected skin and eyes to bright light during infusion and for 48 hours afterwards.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA68",
                        "label": "www.nice.org.uk/TA68"
                    }
                ],
                "fundingIdentifier": "NICE TA68",
                "textContent": "Verteporfin photodynamic therapy for wet age-related macular degeneration (September 2003) Photodynamic therapy is recommended for wet age-related macular degeneration with a confirmed diagnosis of classic (no occult) subfoveal choroidal neovascularisation and best-corrected visual acuity of 6/60 or better. Photodynamic therapy is not recommended for wet age-related macular degeneration with predominantly classic but partly occult subfoveal choroidal neovascularisation except in clinical studies.\n\nwww.nice.org.uk/TA68",
                "html": "<p outputclass=\"title\">Verteporfin photodynamic therapy for wet age-related macular degeneration (September 2003)</p> <p>Photodynamic therapy is recommended for wet age-related macular degeneration with a confirmed diagnosis of classic (no occult) subfoveal choroidal neovascularisation and best-corrected visual acuity of 6/60 or better. </p> <p>Photodynamic therapy is <b>not</b> recommended for wet age-related macular degeneration with predominantly classic but partly occult subfoveal choroidal neovascularisation <i>except</i> in clinical studies.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA68\">www.nice.org.uk/TA68</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77490",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77490",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}